List of articles in "Drug" category - Page 49

5-MeO-NBpBrT (5-Methoxy-N-(4-bromobenzyl)tryptamine) is a drug which acts as an antagonist for the 5-HT2A receptor with a claimed 100x selectivity over the closely related 5-HT2C receptor. While N-benzyl substitution of psychedelic […]

Bay R 1531 is a tricyclic tryptamine derivative which acts as a selective serotonin receptor 5-HT1A agonist. It was researched unsuccessfully for the treatment of stroke but remains in use […]

RU-28306 is a tricyclic tryptamine derivative which acts as a serotonin receptor agonist with selectivity for 5-HT1 and 5-HT2 subtypes. It can be regarded either as a conformationally constrained derivative […]

Technetium (99mTc) mebrofenin is a diagnostic radiopharmaceutical with no known pharmacologic action at recommended imaging doses. Under the brand name Choletec it is available through Bracco Diagnostic Inc. Supplied as […]

Nitrosoprodenafil is a designer drug found in herbal aphrodisiac products which is a novel nitrosated analogue of sildenafil (Viagra). It has an innovative structure which acts as a prodrug breaking […]

OSU-6162 (PNU-96391) is a compound which acts as a partial agonist at both dopamine D2 receptors and 5-HT2A receptors. It acts as a dopamine stabilizer in a similar manner to […]

IBNtxA is an atypical opiate analgesic drug derived from naltrexone. In animal studies it produces potent analgesic effects which are blocked by levallorphan and so appear to be μ-opioid mediated […]

Monoctanoin is a monoglyceride used to dissolve gallstones that are caused by cholesterol.

C16 or PKRi is a drug which acts as a selective inhibitor of the enzyme double-stranded RNA-dependent protein kinase (PKR). It has been shown to effectively inhibit PKR function in […]

Ibrutinib (USAN also known as PCI-32765 and marketed in the U.S. under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It was approved by the US FDA in […]